Literature DB >> 3766604

Giant cell arteritis of the legs. Clinical isolation of severe disease with gangrene and amputations.

G M Greene, D Lain, R M Sherwin, J E Wilson, B M McManus.   

Abstract

Giant cell arteritis rarely presents as clinically advanced extra-ocular ischemia or gangrene. Clinically isolated leg involvement with amputation is even more unusual. A 69-year-old woman is described who had giant cell arteritis necessitating bilateral leg amputations. No other clinical sequelae have ensued during a four-year follow-up period. Temporal artery biopsy subsequent to the amputations revealed no arteritis. Disparities between the usual patterns of clinical and anatomic involvement in giant cell arteritis underlie the potential diagnostic difficulties in this disease. Although typically diagnostic, temporal artery biopsy does not always bridge the clinical and anatomic disparities.

Entities:  

Mesh:

Year:  1986        PMID: 3766604     DOI: 10.1016/0002-9343(86)90568-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  8 in total

Review 1.  Giant cell arteritis presenting as limb claudication.

Authors:  R A Watts; M Coppen; A K Bhalla; A I Binder
Journal:  J R Soc Med       Date:  1989-01       Impact factor: 5.344

Review 2.  Lower extremity vasculitis in polymyalgia rheumatica and giant cell arteritis.

Authors:  Tanaz A Kermani; Kenneth J Warrington
Journal:  Curr Opin Rheumatol       Date:  2011-01       Impact factor: 5.006

Review 3.  Giant cell arteritis: difficult decisions in diagnosis, investigation and treatment.

Authors:  E W Paice
Journal:  Postgrad Med J       Date:  1989-10       Impact factor: 2.401

4.  Large vessel vasculitis without temporal artery involvement: isolated form of giant cell arteritis?

Authors:  M Lambert; A Weber; B Boland; J F De Plaen; J Donckier
Journal:  Clin Rheumatol       Date:  1996-03       Impact factor: 2.980

5.  The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease.

Authors:  Martin A Walter; Ralph A Melzer; Christian Schindler; Jan Müller-Brand; Alan Tyndall; Egbert U Nitzsche
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-04       Impact factor: 9.236

Review 6.  Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data.

Authors:  Tarik Belhocine; Daniel Blockmans; Roland Hustinx; Johan Vandevivere; Luc Mortelmans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-17       Impact factor: 9.236

Review 7.  Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis.

Authors:  Francois Chasset; Camille Francès
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 10.817

Review 8.  The role of 18F-FDG PET/CT in large-vessel vasculitis: appropriateness of current classification criteria?

Authors:  H Balink; R J Bennink; B L F van Eck-Smit; H J Verberne
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.